Insomnia News and Research

Latest Insomnia News and Research

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

23 Apr 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Afghanistan's geography is dominated by a collection of craggy peaks, the highest-a mountain known as Noshaq-has been measured to 7,492 meters. Consequently, the soldiers on duty in this mountainous terrain must often ascend to great heights as part of their duty.

22 Apr 2013

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics, Inc. today announced that a proof-of-concept trial found dalfampridine extended release tablets, marketed as AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, improved walking in people with post-stroke deficits.

16 Apr 2013

New research shows effects of long-term use of opioid therapy

Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows.

15 Apr 2013

Study: Transcendental meditation reduces posttraumatic stress in African refugees

A significant percentage of veterans returning from wars exhibit symptoms of posttraumatic stress (PTS). This is now recognized as a serious health problem, but what about the victims of such violence? Refugees live with the constant reminder of what war has done to their lives and those of their families.

9 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

Free online sleep disorders guide for all professionals in primary care

The National Sleep Foundation is pleased to announce the launch of a comprehensive free online sleep disorders resource for all professionals in primary care. The "Sleep Disorders" guide is the updated web version of Dr. Peter Hauri's book, The Sleep Disorders, first published in 1977.

3 Apr 2013

Racial disparties in autism treatment

The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.

29 Mar 2013

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences, Inc. today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated.

27 Mar 2013

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

VIVUS, Inc. announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

25 Mar 2013

Alarming report on persistent side effects of antidepressant drugs published online

An alarming report from patient online websites on persistent side effects of antidepressant drugs has been published in one of the last issue of Psychotherapy and Psychosomatics by investigators from the University of Bologna and North America.

21 Mar 2013

Prescribing attention-boosting drugs for healthy kids is misguided

The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided.

14 Mar 2013

Burnt-out employees have increased risk of heart disease, researcher finds

Americans work longer hours, take fewer vacation days, and retire later than employees in other industrialized countries around the globe.

13 Mar 2013

Antipsychotic drugs associated with increased risk of stroke in the elderly

Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into this important relationship.

12 Mar 2013

Heart failure risk identified in people with insomnia

People with insomnia appear to be at increased risk for developing heart failure, findings from a large Norwegian cohort study show.

8 Mar 2013

Laboratorios Grifols, Cadence announce new supply agreement for OFIRMEV

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.

6 Mar 2013

Insomnia News and Research

Latest Insomnia News and Research

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

New research shows effects of long-term use of opioid therapy

Study: Transcendental meditation reduces posttraumatic stress in African refugees

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Free online sleep disorders guide for all professionals in primary care

Racial disparties in autism treatment

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Alarming report on persistent side effects of antidepressant drugs published online

Prescribing attention-boosting drugs for healthy kids is misguided

Burnt-out employees have increased risk of heart disease, researcher finds

Antipsychotic drugs associated with increased risk of stroke in the elderly

Heart failure risk identified in people with insomnia

Laboratorios Grifols, Cadence announce new supply agreement for OFIRMEV

Phase III success with extended-release carbidopa–levodopa formulation

Poll shows compelling association between exercise and better sleep

Adult sleepwalking may induce violent behaviors and affect health-related quality of life

COPD benzodiazepine warning

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Insomnia News and Research

Latest Insomnia News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in